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I recently incidentally noted a nasal skin lesion when reviewing a post-operative Dupuytren's patient. As we were arranging to biopsy the lesion, I was surprised to hear him remark that he was unaware that plastic surgeons 'do skin cancer'. I wondered how representative this mis-conception might be, not only throughout the general public, but also in the medical community. I had previously taken an awareness of the role of plastics surgeons in skin cancer management for granted. Could it be that we have, as a craft group, become complacent in promoting the importance of plastic surgery in skin cancer treatment? And could it be that in that state of complacency, we have failed to stay adequately abreast of the revolutionary and rapidly-evolving developments in research and therapeutics in this dynamic field?
This incident prompted me to ponder several key challenges and questions facing plastic surgeons involved in treating skin cancer:
Has the role of plastic surgeons diminished in the changing landscape of skin cancer treatment options, and if so, why? A changing workforce
Both the Royal Australasian College of Surgeons (RACS) and the Australian Society of Plastic Surgeons (ASPS) have always been in favour of patients receiving gold-standard, world class treatment from any practitioner that is fully trained and appropriately accredited to deliver it. In recent years, skin cancer has begun to be treated by a wider range of health practitioners, using an expanding array of treatments. Many non-plastic surgery groups have entered the skin cancer 'space' recently, and focussing solely on skin cancer, they devote considerable time and advertising expenditure promoting themselves to the public. However, a large proportion of new entrants into the field as 'skin cancer surgeons' are not actually surgeons who have completed training through RACS. Members of the public are often unaware of this fact. Many of these doctors are general practitioners (GPs), educated in a relatively short period through newly-formed 'colleges' or 'internally regulated' groups and not accredited with a recognised peak college or public teaching hospital. These skin cancer courses may range from months to two to three years in durationin contrast to the typical five to eight years taken for post-internship specialist reconstructive plastic surgery training. Due to the system of GPs as 'gatekeepers' of referrals to plastic surgeons, however, GPs with a skin cancer interest may see skin cancer patients 'off the street' without a referral, or direct them to another GP in the same practice, rather than onward to a specialist plastic surgeon.
This trend is becoming more commonplace and is likely to increase in the future, but is this situation best for the patient? Certainly, competition and choice is usually healthy and increased numbers of practitioners improves access for patients. Indeed, our growing population needs better access to skin cancer-trained doctors and in a more expeditious time frame. From a health economies point of view and from the perspective of facilitating faster triage, it may be that a 'simple excision' by plastic surgeons becomes a thing of the past.
Changing patient expectations and demographics
Today's society demands instantaneous service.
Despite improving access to doctors, however, Similarly, and all-too-often in these high-risk groups, we encounter examples in which inadequate oncological margins are accepted by a treating doctor, despite clear NHMRC guidelines to advise otherwise. This may be due to logistical reasons, medical comorbidities that make them high-risk in the first place, or a lack of confidence in managing the resulting defect. For example, we see cases of patients with numerous courses of topical treatment used on a tumour that has been refractory because the patient is deemed too highrisk for surgery or the area of the body too complex.
In the end however, the resulting tumour may necessitate a needlessly large or complex resection and reconstruction, or palliative procedures. This scenario is seen commonly in the scalp of elderly or 
What impact has the changing nature of skin cancer treatment had on how plastic surgeons practice?
The evolving landscape of cancer treatment, including in the area of skin cancer, mandates that plastic surgeons become conversant with new innovations in surgical and non-surgical treatments; and that they integrate seamlessly with complimentary specialists to provide optimal multidisciplinary care, where required.
Topical agents
Numerous topical or non-surgical skin cancer Overall, the modern plastic surgeon has to employ a knowledge that also encompasses new technologies and the indications in which they may be used to better treat our patients; often in collaboration with dermatologists, pathologists, skin cancer GPs, and medical and surgical oncologists.
What role do plastic surgeons have in the management of skin cancer into the future?
It is my belief that plastics surgeons continue to play an invaluable role in skin cancer diagnosis and management particularly in the area of high- It is true, however, that the modern skin cancer specialist must be abreast of all aspects of treatment;
and it is also true that a far greater emphasis is paid in non-plastic surgery journals to the nonsurgical treatments for skin cancer. It is critical, therefore, that plastic surgeons be conversant in the latest trends in order to meaningfully integrate into the increasingly complex world of the multidisciplinary team. Therefore, they must also I believe it is the remit of this section of AJOPS to provide a forum for such education, incorporating knowledge and research from all specialty craftgroups. It also provides the forum for us to discuss and enhance our evolving role in the field and to progress our standard of skin cancer practice for the benefit of our patients.
Steps for plastic surgeons to take as a specialty 
Conclusion
Presented here are some of the questions that we need to consider and provide solutions for, if we are to retain the traditional importance of the plastic surgeon as part of the skin cancer team.
As the AJOPS section editor for melanoma and skin cancer, I encourage all plastic surgeons to have input into this important subsection of a new plastic surgery journal.
I hope that part of my role as section editor will be to encourage a forum for active debate regarding the place we hold in the spectrum of skin cancer practitioners and whether we do, indeed, deserve to be there. We may not rest on our laurels.
The melanoma and skin cancer section in AJOPS will also be used to provide accessible information and education for plastic surgeons regarding the fast-moving field of skin cancer research and finally, to provide a forum in which to foster Australasian Journal of Plastic Surgery Volume 1 Number 1 2018 41 AJOPS | EDITORIAL melanoma and skin cancer research by plastic surgeons themselves. We hope that together, such a combined approach will aid plastic surgery in being the best specialty that it can be in the area of melanoma and skin cancer, in the provision of a unique skill set and clinical perspective that we possess, for the betterment of our patients and for the upholding of professional standards in this field.
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